Cancer Research
Cancer is a term used to define a group of diseases in which abnormal cells divide without control, are able to invade neighboring tissues/organs and metastasize. Cancer has been characterized by six hallmarks; self sufficiency in proliferative growth signals, insensitivity to growth inhibitors, evasion of apoptosis, limitless replicative potential, ability to develop blood vessels (angiogenesis), and tissue invasion and metastasis.
Cancer Research Products Areas
- Cell Cycle(111)
- Cancer Immunology(189)
- Cancer Metabolism(47)
- Angiogenesis(88)
- Apoptosis(88)
- Epigenetics in Cancer(113)
- Intracellular Signaling(659)
- Metastasis(101)
- Growth Factors and Cytokines(125)
- Others(22)
Products for Cancer Research
- Cat.No. Product Name Information/Activity
-
BCC2125
Geldanamycin
Selective Hsp90 inhibitor; breast cancer stem cell inhibitor,Geldanamycin is a natural existing HSP90 inhibitor with Kd of 1.2 μM, specifically disrupts glucocorticoid receptor (GR)/HSP association.
-
BCC3690
Verteporfin
Verteporfin (CL 318952) is a photosensitizer for photodynamic therapy to eliminate the abnormal blood vessels in the eye associated with conditions such as age-related macular degeneration. Verteporfin is a YAP inhibitor which disrupts YAP-TEAD interactions. Verteporfin induces cell apoptosis.Verteporfinis an autophagy inhibitor that blocks autophagy at an early stage by inhibiting autophagosome formation.
-
BCC3869
Thioridazine HCl
Selective inducer of CSC differentiation; anticancer agent,Thioridazine is an antipsychotic drug, used in the treatment of schizophrenia and psychosis, shows D4 selectivity or serotonin antagonism.
-
BCC3987
ML 239
ML239 is a potent and selective inhibitor of breast cancer stem cells, with an IC50 of 1.16 μM.
-
BCC4850
STF-118804
STF-118804 is a highly specific NAMPT inhibitor; reduces the viability of most B-ALL cell lines with IC50 <10 nM.
-
BCC5081
Niclosamide
Niclosamide (BAY2353) is an orally bioavailable chlorinated salicylanilide, with anthelmintic and potential antineoplastic activity. Niclosamide (BAY2353) inhibits STAT3 with IC50 of 0.25 μM in HeLa cells and inhibits DNA replication in a cell-free assay.
-
BCC6525
Napabucasin
Napabucasin is a STAT3 inhibitor which blocks stem cell activity in cancer cells.
-
BCC7880
SC 26196
SC-26196 is a potent, orally active Delta6 desaturase (D6D) inhibitor (IC50=0.2 µM in a rat liver microsomal assay). Antiinflammatory properties.
-
BCC7882
CP 100356 hydrochloride
142715-48-8
-
BCN2964
Cyclopamine
Cyclopamine is a Hedgehog (Hh) pathway antagonist with an IC50 of 46 nM in the Hh cell assay.